this blunderbuss therapy , removing as it does inflammatory mediators such as fibrin split products and complement breakdown products , immune complexes , antibodies , drugs and antigens , has been most clearly shown to have therapeutic effect in antibody-mediated diseases such as goodpastures syndrome and myasthenia gravis .
C0003313
immune complexes
C0003241
antibodies